Brazil vs Togo: Treatment success rate for patients treated for MDR-TB
Brazil
60.0%
in 2022
Togo
60.0%
in 2022
Brazil rank
120th
Togo rank
120th
Treatment success rate for patients treated for MDR-TB over time
- Brazil
- Togo
How they compare
Brazil currently reports 60.0% against 60.0% in Togo, a difference of 0.0%.
The two have swapped places 4 times across 13 shared years of data; in 2007 it was Togo ahead.
Brazil ranks 120th and Togo ranks 120th of 163 countries.
Togo has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Brazil | Togo | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 46.5% | 75.0% | 28.5% | Togo |
| 2010s | 55.5% | 72.6% | 17.1% | Togo |
| 2020s | 55.3% | 61.7% | 6.3% | Togo |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Brazil or Togo?
- Brazil, at 60.0% against 60.0% in Togo as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Brazil and Togo?
- 0.0%, with Brazil ahead.
- How many years of comparable data are there for Brazil and Togo?
- 13 years are reported by both, from 2007 to 2022.
- How do Brazil and Togo rank globally for treatment success rate for patients treated for mdr-tb?
- Brazil ranks 120th and Togo ranks 120th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.